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Abstract 
Background: 2,3-Butanediol is an important bulk chemical with a wide range of applications. In bacteria, this metab-
olite is synthesised from pyruvate via a three-step pathway involving α-acetolactate synthase, α-acetolactate decar-
boxylase and 2,3-butanediol dehydrogenase. Thus far, the best producers of 2,3-butanediol are pathogenic strains, 
hence, the development of more suitable organisms for industrial scale fermentation is needed. Herein, 2,3-butan-
ediol production was engineered in the Generally Regarded As Safe (GRAS) organism Corynebacterium glutamicum. A 
two-stage fermentation process was implemented: first, cells were grown aerobically on acetate; in the subsequent 
production stage cells were used to convert glucose into 2,3-butanediol under non-growing and oxygen-limiting 
conditions.
Results: A gene cluster, encoding the 2,3-butanediol biosynthetic pathway of Lactococcus lactis, was assembled 
and expressed in background strains, C. glutamicum ΔldhA, C. glutamicum ΔaceEΔpqoΔldhA and C. glutamicum 
ΔaceEΔpqoΔldhAΔmdh, tailored to minimize pyruvate-consuming reactions, i.e., to prevent carbon loss in lactic, 
acetic and succinic acids. Producer strains were characterized in terms of activity of the relevant enzymes in the 
2,3-butanediol forming pathway, growth, and production of 2,3-butanediol under oxygen-limited conditions. 
Productivity was maximized by manipulating the aeration rate in the production phase. The final strain, C. glutami-
cum ΔaceEΔpqoΔldhAΔmdh(pEKEx2-als,aldB,PtufbutA), under optimized conditions produced 2,3-butanediol with a 
0.66 mol mol−1 yield on glucose, an overall productivity of 0.2 g L−1 h−1 and a titer of 6.3 g L−1.
Conclusions: We have successfully developed C. glutamicum into an efficient cell factory for 2,3-butanediol produc-
tion. The use of the engineered strains as a basis for production of acetoin, a widespread food flavour, is proposed.
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Background
Concern over exhaustion of fossil fuel resources, emis-
sion of CO2 linked with petroleum-derived products, 
and accumulation of non-degradable synthetic polymers 
urged the development of environmentally friendly pro-
cesses for production of chemicals. A solution offered 
by the rising field of white biotechnology is to produce 
chemical building blocks by microbial fermentation of 
sugars derived from renewable biomass [1].
2,3-Butanediol (2,3-BD) is an important chemical used 
in the production of plasticizers and fumigants, as an 
antifreeze agent, a fuel and octane booster, among other 
applications [2]. The range is still expanding and the mar-
ket size is expected to reach 74 kilo tons by 2018 [3]. Sig-
nificantly, the 2,3-BD derivative, 1,3-butanediene, can be 
used in synthetic rubber production, while 2-butanone 
(methyl ethyl ketone) is a fuel additive and solvent for 
resins and lacquers. Additionally, ester-derivatives are 
used in the pharmaceutical and cosmetics industries [2]. 
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The world annual market for 2,3-BD derivatives is esti-
mated at around $43 billion [4].
2,3-BD has three stereoisomeric forms: the enantiom-
ers (2S,3S)-2,3-BD and (2R,3R)-2,3-BD, and the optically 
inactive form (2R,3S)-2,3-BD (meso-2,3-BD). 2,3-BD is 
an end-product of the metabolism of many bacteria, syn-
thesized from pyruvate via a three step pathway (Fig. 1). 
The first reaction involves the condensation of two pyru-
vate molecules into α-acetolactate, which is catalyzed by 
α-acetolactate synthase (ALS, EC 2.2.1.6), the enzyme 
committed to pyruvate catabolism. Alternatively, as in 
Corynebacterium glutamicum, α-acetolactate can be 
synthesized by the action of acetohydroxyacid synthase 
(AHAS, EC 2.2.1.6, encoded by ilvBN), and used as pre-
cursor for the synthesis of branched chain amino acids 
(l-valine, l-leucine and l-isoleucine). In the catabolic 
route, α-acetolactate is decarboxylated by α-acetolactate 
decarboxylase (ALDC, EC 4.1.1.5, encoded by aldB) to 
yield R-acetoin. In the presence of oxygen, α-acetolactate 
can undergo spontaneous decarboxylation to form dia-
cetyl, which is subsequently reduced to R- or S-acetoin by 
diacetyl reductases (EC 1.1.1.303; EC 1.1.1.304). Acetoin 
is finally reduced to 2,3-BD by butanediol dehydroge-
nases (BDH, EC 1.1.1.76; EC 1.1.1.4). In some cases, such 
as C. glutamicum or L. lactis, BDH is promiscuous and 
recognizes as substrates diacetyl as well as acetoin, thus 
diacetyl can be reduced to acetoin via this activity [5, 6].
Thus far, the best producers of 2,3-BD are pathogenic 
strains, such as Klebsiella pneumoniae, Klebsiella oxy-
toca, Enterobacter aerogenes, and Serratia marcescens 
[7–10], hence, a considerable research effort has been 


















































































Fig. 1 A scheme depicting major pyruvate consuming reactions, including the proposed pathway for synthesis of optically active 2,3-BD in C. 
glutamicum and the strategy for engineering meso-2,3-BD synthesis. L. lactis genes of the 2,3-BD biosynthetic pathway (green) were introduced 
into C. glutamicum. Endogenous genes of interest are presented in blue; the red cross marks indicate genes that were inactivated in host strains to 
prevent the production of lactic acid (ldhA) and acetic acid (aceE and pqo); suppression of succinic acid was attempted by deletion of mdh. mdh, 
malate dehydrogenase gene; mqo, malate:quinone oxidoreductase gene; ALS, α-acetolactate synthase (encoded by als); ALDC, α-acetolactate 
decarboxylase (encoded by aldB); BDH, butanediol dehydrogenase (encoded by butA), AHAS, acetohydroxyacid synthase; LDH, lactate dehydro-
genase (encoded by ldhA); PQO, pyruvate:quinone oxidoreductase (encoded by pqo); AlaT, alanine-glutamate transaminase; AvtA, alanine-valine 
transaminase; AceE, E1-subunit of the pyruvate dehydrogenase complex (encoded by aceE); Pta-Ack, phosphotransacetylase and acetate kinase; 
PCx, pyruvate carboxylase
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for industrial scale fermentation. Lactococcus lactis, 
Bacillus subtilis, Paenibacillus polymyxa, Saccharomy-
ces cerevisiae and Escherichia coli have been used for 
this purpose, but the low production efficiency or com-
plex nutritional requirements of the engineered strains 
make the overall process unsatisfactory [11–15]. There-
fore, the search goes on for more appropriate host strains 
and more efficient fermentation processes. A few years 
ago, some of us engineered L. lactis for the production 
of 2,3-BD by overexpression of two endogenous genes 
(als, butA) [11]; theoretical product yields were reached, 
but the fastidious nutritional requisites of this bacterium 
precludes its utilization as an industrial producer of bulk 
chemicals.
In this work, we selected Corynebacterium glutami-
cum as an industrially established host strain and aimed 
to develop an efficient 2,3-BD producer. C. glutamicum 
is an important industrial microorganism, widely known 
for the million-ton scale production of l-glutamate 
and l-lysine [16]. Therefore, the existing knowledge of 
the industrial fermentation of this bacterium could be 
exploited for the production of bulk chemicals, such as 
2,3-BD. In addition, C. glutamicum is a facultative anaer-
obic organism with GRAS (Generally Regarded As Safe) 
status, robust (osmotolerant, phageresistant, organic 
solvent tolerant), extensively studied with respect to 
metabolism and regulation, and for which a comprehen-
sive toolbox for genetic manipulation has been developed 
[17–19]. Considerable research effort has been invested 
in metabolic engineering of C. glutamicum, resulting in 
the construction of producer strains for a broad spec-
trum of compounds, such as biofuels (isobutanol and 
ethanol), polymer precursors (diaminopentane, cadaver-
ine and putrescine), sugar alcohols (xylitol) and organic 
acids [20–29]. As a result of this research endeavour, 
platform strains of C. glutamicum have been established. 
More specifically, strains deficient in l-lactate dehydro-
genase (LDH, encoded by ldhA) have been proven to 
be a useful starting point for strain development since 
deletion of the ldhA gene eliminates l-lactate forma-
tion, concomitantly increasing NADH availability [27, 
29]. In addition, strains deficient in the aceE-encoded E1 
subunit of the pyruvate dehydrogenase complex (PDHC) 
were also shown to be suitable hosts for the production 
of pyruvate and pyruvate-derived products, l-valine, 
l-lysine, 2-ketoisovalerate, succinate and isobutanol 
(reviewed in [30]). Typically, PDHC-deficient strains are 
unable to grow on glucose as sole carbon source unless 
the medium is supplemented with acetate or ethanol [31, 
32]. However, in the absence of the latter substrates, C. 
glutamicum ΔaceE remains metabolically active and 
converts glucose to pyruvate, l-alanine and l-valine 
under aerobic conditions [30]. Combined activities of 
pyruvate:quinone oxidoreductase, acetate kinase and 
phosphotransacetylase (Fig.  1) do not provide sufficient 
acetyl-CoA to replace the PDHC reaction in glucose con-
taining medium, however, deletion of the respective pqo 
gene was shown to be beneficial for the production of 
pyruvate and its derived products l-valine and 2-ketois-
ovalerate [33, 34]. In this framework, we constructed and 
tested three strains as potential hosts for efficient 2,3-BD 
production. In addition to C. glutamicum ΔldhA, and C. 
glutamicum ΔaceEΔpqoΔldhA, designed to minimize lac-
tate and acetate formation, a third strain, C. glutamicum 
ΔaceEΔpqoΔldhAΔmdh, was constructed with an extra 
deletion of the malate dehydrogenase gene to reduce suc-
cinate formation (Fig.  1). In these strains we expressed 
als, aldB, butA from L. lactis and devised a two-stage 
process for efficient production of 2,3-BD. In the first 
stage cells were grown aerobically on acetate or glucose 
for biomass formation; in the second stage (production 
stage), biomass was used to convert glucose into 2,3-BD 
under non-growing and oxygen-limiting conditions.
Results
Design of a synthetic pathway for 2,3‑BD and functional 
analysis
The first step in engineering C. glutamicum for the syn-
thesis of 2,3-BD was to construct an artificial operon 
comprising als, aldB, and butA that form the 2,3-BD 
biosynthetic pathway of L. lactis. The three genes were 
cloned into pEKEx2 expression vector under control 
of the isopropyl β-D-1-thiogalactopyranoside (IPTG)-
inducible Ptac promoter (Additional file  1: Fig. S1), 
and transformed into the three selected background 
strains C. glutamicum ΔldhA, ΔaceEΔpqoΔldhA and 
ΔaceEΔpqoΔldhAΔmdh (Table  1). To evaluate whether 
the target enzymes were functionally produced, spe-
cific activities were determined in cell extracts (Table 2). 
Induced expression of als and aldB genes in C. glu-
tamicum ΔldhA(pEKEx2-als,aldB,butA) led to 61- 
and 15-fold increase in ALS/ALDC activity when 
compared to control C. glutamicum Δldh(pEKEx2) 
grown on glucose and acetate, respectively; this cor-
responded to an increase from 0.024  ±  0.003 to 
1.47  ±  0.42  U  (mg of protein)−1 in glucose grown 
cells, and from 0.037  ±  0.002 to 0.54  ±  0.09  U  (mg 
of protein)−1 in acetate grown cells. For C. glutami-
cum ΔaceEΔpqoΔldhA(pEKEx2-als,aldB,butA), ALS/
ALDC activity was increased 17-fold (0.034  ±  0.001 
compared to 0.58 ±  0.12  U  (mg of protein)−1), and for 
ΔaceEΔpqoΔldhAΔmdh(pEKEx2-als,aldB,butA) the 
activity was 8-fold higher (0.055  ±  0.019 compared to 
0.43  ±  0.04  U  (mg of protein)−1). The activity of BDH 
in strain ΔldhA(pEKEx2-als,aldB,butA) doubled in glu-
cose grown cells, and, unexpectedly, decreased twofold 
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(from 0.2 to 0.1  U  (mg of protein)−1) in acetate-grown 
cells, when compared to the control strain cultivated 
under the same conditions. Acetate grown C. glutami-
cum ΔaceEΔpqoΔldhA(pEKEx2-als,aldB,butA) and 
ΔaceEΔpqoΔldhAΔmdh(pEKEx2-als,aldB,butA) showed 
3- and 8-fold increase in BDH activity, compared to 
the control strain. Maximal specific activity values of 
0.97  ±  0.19  U  (mg of protein)−1 were obtained. In an 
attempt to increase BDH activity further we cloned 
the constitutive Ptuf promoter [28, 35] in front of butA, 
yielding pEKEx2-alsaldBPtufbutA (Additional file  1: Fig. 
S1). However, this increased BDH activity only slightly 
(Table 2).
Growth profiles of engineered strains
First, we characterized growth and biomass formation of 
the engineered strains in shake-flasks in 2× TY medium 
containing glucose or acetate (Additional file  1: Fig. S2, 
Table S1). The ΔaceE strains (PDHC-deficient) are una-
ble to grow on glucose as sole carbon source, therefore, 
they were grown aerobically on acetate alone. Strains 
C. glutamicum Δldh(pEKEx2) and ΔldhA(pEKEx2-
als,aldB,butA) were grown on glucose and also on acetate 
for comparison purposes. While the control strain C. 
glutamicum Δldh(pEKEx2) had similar specific growth 
rates when grown on glucose or acetate (0.52  ±  0.02 
and 0.51  ±  0.05  h−1, respectively), ΔldhA(pEKEx2-
als,aldB,butA) displayed a lower growth rate on acetate 
(0.46  ±  0.01 versus 0.58  ±  0.01  h−1). The pH profiles 
were also dependent on the substrate used for growth as 
glucose-grown cells presented a sharper decrease in pH 
at the onset of stationary phase (Additional file 1: Fig. S2). 
The biomass formation was fairly similar for C. glutami-
cum Δldh(pEKEx2) and producer strain ΔldhA(pEKEx2-
als,aldB,butA) regardless of the substrate used for growth 
(maximal OD600 values in the range 21–24). The C. glu-
tamicum ΔaceEΔpqoΔldhA-derived producers showed 
growth and pH profiles identical to those of the control 
strain ΔaceEΔpqoΔldhA(pEKEx2). The specific growth 
rate of C. glutamicum ΔaceEΔpqoΔldhAΔmdh(pEKEx2-
als,aldB,butA) was higher as compared to the control 
strain ΔaceEΔpqoΔldhAΔmdh(pEKEx2) (0.55  ±  0.04 
Table 1 Bacterial strains and plasmids used in this study
als α-acetolactate synthase gene, aldB α-acetolactate decarboxylase gene, butA butanediol dehydrogenase gene, Ptuf a 185 bp region upstream of tuf gene of C. 
glutamicum, kanR kanamycin resistance, Ptrc trc promoter, lacI lac repressor gene
Strains Description Reference
E. coli DH5α Plasmid-free E. coli Amersham biosciences
C. glutamicum ATCC13032 Wild-type strain [60]
C. glutamicum ΔldhA ATCC13032 with deletion of lactate dehydrogenase gene ldhA This study
C. glutamicum ΔaceEΔpqoΔldhA ATCC13032 with deletions of the genes for the E1 subunit of pyruvate dehy-





ATCC13032 with deletions of the genes for the E1 subunit of pyruvate dehydro-
genase complex, the pyruvate:quinone oxidoreductase, lactate dehydroge-




C. glutamicum ΔaceEΔpqoΔldhA harboring plasmid pEKEx2 This study
C. glutamicum ΔldhA (pEKEx2) C. glutamicum ΔldhA harboring plasmid pEKEx2 This study
C. glutamicum ΔaceEΔpqo
ΔldhAΔmdh (pEKEx2)
C. glutamicum ΔaceEΔpqoΔldhAΔmdh harboring plasmid pEKEx2 This study
C. glutamicum ΔldhA (pEKEx2- als,aldB,butA) C. glutamicum ΔldhA harboring plasmid pEKEx2 als,aldB,butA This study
C. glutamicum ΔaceEΔpqo
ΔldhA (pEKEx2-als,aldB,butA)
C. glutamicum ΔaceEΔpqoΔldhA harboring plasmid pEKEx2-als,ald,BbutA This study
C. glutamicum ΔaceEΔpqo
ΔldhAΔmdh (pEKEx2-als,aldB,butA)
C. glutamicum ΔaceEΔpqoΔldhAΔmdh harboring plasmid pEKEx2-als,aldB,butA This study
C. glutamicum ΔaceEΔpqo
ΔldhA (pEKEx2-als,aldB,PtufbutA)
C. glutamicum ΔaceEΔpqoΔldhA harboring plasmid pEKEx2-als,aldB,PtufbutA This study
C. glutamicum ΔaceEΔpqo
ΔldhAΔmdh (pEKEx2-als,aldB,PtufbutA)




 pEKEx2 kanR from pUC4 K; Ptrc, lacI, pUC18 mcs, induced by addition of IPTG [61]
 pEKEx2-als pEKEx2 with cloned als from L. lactis This study
 pEKEx2-als,aldB,butA pEKEx2-als with cloned aldB and butA from L. lactis This study
 pEKEx2-als,aldB,PtufbutA pEKEx2-als with cloned aldB and Ptuf-butA from L. lactis This study
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vs 0.46 ±  0.01 h−1); on the other hand, the growth rate 
of ΔaceEΔpqoΔldhAΔmdh(pEKEx2-als,aldB,PtufbutA) 
was comparable to that of the control strain (0.44 ± 0.01 
vs 0.46  ±  0.01  h−1). For all ΔaceEΔpqoΔldhA- and 
ΔaceEΔpqoΔldhAΔmdh-derived strains, the initial and 
final pH values were 7.1 and 9.2, respectively, and maxi-
mal OD600 values were in the range 15–19. In summary, 
cell growth was not impaired by the expression of heter-
ologous genes (Additional file 1: Table S1), reflecting the 
robustness of these platform strains.
Characterization of 2,3‑BD production under low‑oxygen 
conditions
The production of reduced compounds, such as 2,3-BD, 
is expected to be maximal under oxygen limiting condi-
tions. Having this in mind, we devised a strategy for the 
production of 2,3-BD in which aerobically grown cells 
are collected, washed, re-suspended in minimal medium 
and provided with glucose under oxygen limiting condi-
tions. Oxygen concentration was not measured, but the 
observed formation of organic acids indicated restricted 
oxygen availability (Fig. 2).
In a first attempt to reduce pyruvate consuming reac-
tions leading to end-products other than 2,3-BD, we 
used as background C. glutamicum ΔldhA. During the 
production phase, glucose-grown cells produced 2,3-
BD with a yield of 0.05 mol per mol of glucose (Table 3, 
Additional file  1: Table S3); the yield was even lower 
for cells grown on acetate (0.02  mol per mol of glu-
cose). The glucose consumption rate (GCR) was low, 
i.e., 2.5 ±  0.4  nmol  min−1  mg  CDW−1. For comparison 
purposes, the GCR of the wild type strain (grown on 
acetate) was determined in a similar experimental set-up 
to give 24.6 ± 0.5 nmol min−1 mg CDW−1. Actually, this 
value agrees perfectly with 25  nmol  min−1  mg  CDW−1, 
the GCR reported earlier for wild type C. glutamicum 
with a different experimental set-up [36]. Importantly, 
the introduction of the lactoccocal pathway had a posi-
tive effect on GCR in glucose grown C. glutamicum 
ΔldhA(pEKEx2-als,aldB,butA) (4.4 ± 0.4 nmol min−1 mg 
CDW−1 compared to 2.5 ± 0.4 nmol min−1 mg CDW−1 
in the control strain), and no effect on acetate grown cells 
(3.4 ± 0.4 compared to 3.0 ± 0.2 nmol min−1 mg CDW−1 
in the control strain). 2,3-BD produced by the engi-
neered strain ΔldhA(pEKEx2-als,aldB,butA) grown on 
glucose and acetate was, respectively, 34 ± 3 mM (yield 
of 0.34 ± 0.04 mol per mol glucose, a sevenfold increase 
compared to the control strain), and 19.5  ±  0.7  mM 
(0.27  ±  0.06  mol per mol glucose; 11-fold increase). 
Other major products of metabolism were acetate, succi-
nate, and glycerol at respective concentrations of 29 ± 2, 
22 ± 2, 10 ± 1 mM in cells grown on acetate, and 25 ± 6, 
20 ± 1, 19 ± 6 mM in glucose grown cells (Fig. 2, Addi-
tional file 1: Table S3).
The inactivation of the PDHC and PQO in the pro-
ducer strain ΔaceEΔpqoΔldhA(pEKEx2-als,aldB,butA) 
had a drastic effect on 2,3-BD yield that increased 
from 0.27  ±  0.06 in ΔldhA(pEKEx2-als,aldB,butA), to 
0.66 ± 0.05 mol per mol, reflecting primarily the reduc-
tion of acetate formation (from 29 mM to below 0.5 mM). 
Table 2 Overexpression and specific activities of enzymes for the synthesis of 2,3-butanediol as determined in crude cell 
extracts
Cells were grown for 14 h in 2× TY medium supplemented with acetate, unless stated otherwise
Values shown are averages ± SD of at least three independent experiments and two technical replicates
ALS α-acetolactate synthase, ALDC α-acetolactate decarboxylase, BDH butanediol dehydrogenase
* Cells grown on glucose
ALS/ALDC activity  
U (mg of protein)−1






ΔldhA (pEKEx2)* 0.02 ± 0.00 0.66 ± 0.03 – –
ΔldhA (pEKEx2-als,aldB,butA)* 1.47 ± 0.42 1.18 ± 0.26 61 2
ΔldhA (pEKEx2) 0.04 ± 0.00 0.20 ± 0.03 – –
ΔldhA (pEKEx2-als,aldB,butA) 0.54 ± 0.09 0.10 ± 0.03 15 –
ΔaceEΔpqoΔldhA (pEKEx2) 0.03 ± 0.01 0.24 ± 0.04 – –
ΔaceEΔpqoΔldhA (pEKEx2-
als,aldB,butA)
0.58 ± 0.12 0.67 ± 0.01 17 3
ΔaceEΔpqoΔldhA (pEKEx2-
als,aldB,PtufbutA)
1.42 ± 0.24 0.53 ± 0.17 31 2
ΔaceEΔpqoΔldhAΔmdh (pEKEx2) 0.06 ± 0.02 0.11 ± 0.04 – –
ΔaceEΔpqoΔldhAΔmdh (pEKEx2-
als,aldB,butA)
0.43 ± 0.04 0.97 ± 0.19 8 8
ΔaceEΔpqoΔldhAΔmdh (pEKEx2-
als,aldB,PtufbutA)
0.47 ± 0.14 1.21 ± 0.01 9 10











































































































































































Fig. 2 End-products of glucose metabolism in 2,3-BD producers and control strains under oxygen limiting conditions: 25 mL of cell suspen-
sion in stoppered 50-mL flasks incubated with 2 % (wt/vol) glucose for 48 h at 180 rpm and 30 °C. Control strains produced optically active 
2,3-BD (most likely (2S,3S)-2,3-BD), while the engineered strains produced meso-2,3-BD. For simplicity, a single color is used to represent any 
form of 2,3-BD. Lactate dehydrogenase negative strains (a) grown on glucose (left) and acetate (right); triple deletion mutants C. glutamicum 
ΔaceEΔpqoΔldhA(pEKEx2-als,aldB,butA), C. glutamicum ΔaceEΔpqoΔldhA(pEKEx2-als,aldB,PtufbutA) (b) and quadruple deletion mutants C. glutami-
cum ΔaceEΔpqoΔldhAΔmdh(pEKEx2-als,aldB,butA) and C. glutamicum ΔaceEΔpqoΔldhAΔmdh(pEKEx2-als,aldB,PtufbutA) (c). red 2,3-BD; blue acetoin; 
magenta acetolactate; light green succinate; purple acetate; brown pyruvate; dark green α-ketoisovalerate; black DHA; dark grey glycerol; yellow 
l-alanine
Table 3 Glucose (Glc) consumption rate (GCR), molar yield and productivity of 2,3-butanediol (2,3-BD), and carbon recov-
ery (CR) by the control and engineered C. glutamicum strains
In the first phase, cells were grown aerobically on 1 % (wt/vol) potassium acetate except for the strains indicated with an asterisk for which 0.5 % (wt/vol) glucose 
was used instead. Second phase fermentations were carried out for 48 h, using 25 mL of cell suspension in closed 50-mL falcon flasks with glucose as substrate. 
The cardinal symbol indicates that optically active 2,3-BD was produced; remaining strains produced meso-form of 2,3-BD. Values are averages of at least three 
independent experiments. A single NMR spectrum was acquired for each sample
GCR (nmol min−1  
mg  CDW−1)





ΔldhA (pEKEx2)* 2.5 ± 0.4 0.05 ± 0.00# 0.12 ± 0.01 81 ± 3
ΔldhA (pEKEx2- als,aldB,butA)* 4.4 ± 0.4 0.34 ± 0.04 1.28 ± 0.09 79 ± 9
ΔldhA (pEKEx2) 3.0 ± 0.2 0.02 ± 0.01# 0.06 ± 0.03 77 ± 1
ΔldhA (pEKEx2- als,aldB,butA) 3.4 ± 0.4 0.27 ± 0.06 0.53 ± 0.13 82 ± 3
ΔaceEΔpqoΔldhA (pEKEx2) 1.6 ± 0.3 0.22 ± 0.01# 0.30 ± 0.00 87 ± 1
ΔaceEΔpqoΔldhA (pEKEx2-als,aldB,butA) 5.4 ± 0.7 0.66 ± 0.05 3.55 ± 0.58 84 ± 7
ΔaceEΔpqoΔldhA (pEKEx2-als,aldB,PtufbutA) 6.1 ± 0.1 0.61 ± 0.06 3.13 ± 0.22 87 ± 3
ΔaceEΔpqoΔldhAΔmdh (pEKEx2) 1.6 ± 0.3 0.34 ± 0.05# 0.53 ± 0.00 91 ± 6
ΔaceEΔpqoΔldhAΔmdh (pEKEx2-
als,aldB,butA)
6.0 ± 0.3 0.64 ± 0.09 4.34 ± 0.16 90 ± 4
ΔaceEΔpqoΔldhAΔmdh (pEKEx2-
als,aldB,PtufbutA)
6.5 ± 0.5 0.64 ± 0.10 4.25 ± 0.41 91 ± 7
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Moreover, the GCR increased about 1.6-fold and there 
was a sevenfold increase in overall productivity. Glycerol 
and succinate were the major side-products (12 ± 1 and 
8 ± 1 mM, respectively) (Fig. 2).
Further engineering aimed at succinate reduc-
tion (MDH inactivation by deletion of the cg2613-
encoded activity), left both yield and GCR essentially 
unchanged while productivity was slightly improved 
in C. glutamicum ΔaceEΔpqoΔldhAΔmdh(pEKEx2-
als,aldB,butA) (4.3  ±  0.2 compared to 3.6  ±  0.6  nmol   
min−1  mg  CDW−1). Strains in which the lactococ-
cal butA gene was placed under the control of Ptuf pro-
moter showed similar behavior to those which had 
this gene under Ptac control in terms of all production 
parameters (Table  3; Fig.  2). In summary, C. glutami-
cum ΔaceEΔpqoΔldhA(pEKEx2-als,aldB,butA), ΔaceE 
ΔpqoΔldhAΔmdh(pEKEx2-als,aldB,butA) and ΔaceEΔ 
pqoΔldhAΔmdh(pEKEx2-als,aldB,PtufbutA) showed the 
highest yield of about 0.65 mol 2,3-BD per mol of glucose 
with the latter two strains exhibiting the highest produc-
tivities of about 4.3 nmol 2,3-BD per min and mg CDW 
(Table  3). All control strains produced optically active 
2,3-BD, while only the meso-form was found as end-
product of the producer strains (Fig. 2, Additional file 1: 
Table S3).
It is important to note that pH was not controlled dur-
ing the production phase. All fermentations started at 
pH 7.0, but the final pH value varied as mutants exhib-
ited different acidifying properties due to their dif-
ferential ability to produce organic acids. At the end of 
48 h-fermentation, pH was between 5.1 and 5.3 for ldhA-
negative strains. As expected, reduction of succinate 
and acetate, and accumulation of neutral compounds 
led to higher final pH values: 6.6, 6.4, 5.7 and 6.6 for C. 
glutamicum ΔaceEΔpqoΔldhA(pEKEx2-als,aldB,butA), 
ΔaceEΔpqoΔ ldhAΔmdh(pEKEx2-als ,aldB,butA) , 
ΔaceEΔpqoΔldhA(pEKEx2-als,aldB,PtufbutA) and ΔaceE 
ΔpqoΔldhAΔmdh(pEKEx2-als,aldB,PtufbutA), respec-
tively. Earlier work has shown that a decrease in pH 
results in considerably lower GCR in resting cells of wild-
type C. glutamicum [36].
Optimization of 2,3‑BD production by manipulation 
of oxygen supply
Engineered strains of C. glutamicum converted up to 
two-thirds of glucose into 2,3-BD (Table  3), however 
the consumption rate of glucose was not satisfactory 
when compared to other C. glutamicum strains, such as 
those manipulated for the production of isobutanol and 
succinate [20, 28]. The accumulation of reduced com-
pounds, such as succinate and glycerol, hinted that the 
low GCR in the engineered strains could result from a 
high NADH:NAD+ ratio, as previously proposed [37]. 
Oxygen can be an alternative acceptor of electrons 
from NADH, via the electron transfer chain, hence we 
performed fermentations under different controlled 
oxygen supply conditions (sparging rates of 5, 10 or 
20 mL air min−1) in the mini-fermenter as described in 
Methods, to determine the conditions that would sup-
port maximal yield, GCR and productivity (Table  4, 
Additional file  1: Table S4, Fig.  3). Strains C. glutami-
cum ΔaceEΔpqoΔldhA(pEKEx2-als,aldB,PtufbutA) and 
ΔaceEΔpqoΔldhAΔmdh(pEKEx2-als,aldB,PtufbutA) were 
selected for this optimization step as they showed par-
ticularly high ALS/ALDC and BDH activity, respectively.
Cell suspensions of C. glutamicum ΔaceEΔpqo 
ΔldhA(pEKEx2-als,aldB,PtufbutA) and ΔaceEΔpqoΔ 
ldhAΔmdh(pEKEx2-als,aldB,PtufbutA) under constant air 
flow of 5 mL min−1 showed an increased GCR [7.2 ± 0.6 
and 11.1  ±  1.0  nmol  min−1  mg  CDW−1 in mini-fer-
menter for the two respective strains (Table 4), compared 
to 6.1  ±  0.1 and 6.5  ±  0.5  nmol  min−1  mg  CDW−1 in 
flasks (Table 3)]; the productivity in mini-fermenter was 
3.4 ± 0.3 and 5.5 ± 0.7 nmol min−1 mg CDW−1 compared 
Table 4 Glucose (Glc) consumption rate (GCR), molar yield and  productivity of  2,3-butanediol (2,3-BD), and  car-
bon recovery (CR) achieved with  C. glutamicum ΔaceEΔpqoΔldhA(pEKEx2-als,aldB,PtufbutA) and  C. glutamicum 
ΔaceEΔpqoΔldhAΔmdh(pEKEx2-als,aldB,PtufbutA) strains under different aeration conditions
Cells were grown aerobically on 1 % (wt/vol) potassium acetate. The second, production phase was performed in a 80-mL fermenter at 30 °C for 30 h with glucose 
as substrate. The cell suspension was sparged with air at the flow rates indicated. Meso-2,3-BD was by far the major stereoisomer. At the optimal aeration rate 
(10 mL min−1), there was 95 % of the meso-form. Values are averages of three independent experiments; a single NMR spectrum was acquired for each sample
Airflow (mL min−1) GCR (nmol min−1  
mg CDW−1)







5 7.2 ± 0.6 0.44 ± 0.04 3.4 ± 0.3 89 ± 6
10 15.8 ± 1.7 0.57 ± 0.03 8.1 ± 0.4 91 ± 4
20 14.7 ± 1.1 0.36 ± 0.06 5.0 ± 0.9 83 ± 10
ΔaceEΔpqoΔldhAΔmdh 
(pEKEx2-als,aldB,PtufbutA)
5 11.1 ± 1.0 0.52 ± 0.03 5.5 ± 0.7 85 ± 2
10 21.1 ± 0.8 0.66 ± 0.01 10.9 ± 1.8 90 ± 8
20 22.8 ± 1.6 0.46 ± 0.02 8.0 ± 0.7 78 ± 7
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to 3.1  ±  0.2 and 4.3  ±  0.4  nmol  min−1  mg  CDW−1 in 
flasks, but the yield was higher for fermentations in 
closed flasks (Tables 3, 4). Upon doubling of the air flow 
to 10  mL  min−1, GCR and the productivity of C. glu-
tamicum ΔaceEΔpqoΔldhA(pEKEx2-als,aldB,PtufbutA) 
and ΔaceEΔpqoΔldhAΔmdh(pEKEx2-als,aldB,PtufbutA) 
increased two-fold; both strains produced 2,3-BD at 
highest yields (0.57 ±  0.03 and 0.66 ±  0.01 mol 2,3-BD 
per mol glucose). Interestingly, further increase in the 
flow rate to 20 mL min−1 resulted in significantly lower 
yields and productivities (Table  4). Ethanol was pro-
duced by both strains in experiments using 5 mL min−1 
air, and glycerol was absent only in the experiment using 
20  mL  min−1 air with the ΔaceEΔpqoΔldhA(pEKEx2-
als,aldB,PtufbutA) strain. Other side products in these 
experiments were acetoin, succinate, dihydroxyacetone 
(DHA), pyruvate, acetate, l-alanine, α-acetolactate, 
α-ketoglutarate, and α-ketoisovalerate (Fig.  3, Addi-
tional file  1: Table S4). Among these, acetoin forma-
tion showed a clear dependence on oxygen availability, 
increasing about 3- and 5-fold when the air flow was 
increased from 5 to 10  mL  min−1 and from 5 to 
20  mL  min−1, respectively. Dissolved oxygen was not 
controlled, but we confirmed that the oxygen concen-
tration was below the detection limit of the oxygen elec-
trode even at the highest aeration rate. The time course 
for glucose consumption and end-product formation is 
illustrated in Fig. 4 for the best producer strain. In sum-
mary, under an air flow of 10 mL min−1 C. glutamicum 
ΔaceEΔpqoΔldhAΔmdh(pEKEx2-als,aldB,PtufbutA) pro-
duced 70 ±  8  mM 2,3-BD with a yield of 0.66  mol per 
mol of glucose and productivity of 11  nmol  min−1  mg 
CDW−1, which represent a notable improvement 
(Fig. 5).
Discussion
The wild-type C. glutamicum produces vestigial 
amounts of 2,3-BD [38]. Accordingly, low levels of 
2,3-BD were also found in the end-products of glu-
cose metabolism by the control strain C. glutamicum 
ΔldhA(pEKEx2), the initial host in this work (Table 3). 
C. glutamicum was the favored candidate for 2,3-BD 
production given its high performance as an indus-
trial organism and its GRAS status. Moreover, we veri-
fied that 2,3-BD has low toxicity to C. glutamicum as 
cell growth was not affected by 2  % 2,3-BD (data not 
shown). 2,3-BD producing bacteria, such as Klebsiella 
spp., synthesize this diol from pyruvate in a sequence 
of three reactions catalyzed by α-acetolactate synthase, 
α-acetolactate decarboxylase and butanediol dehy-
drogenase. In this work, we constructed an artificial 
operon with the three relevant genes of L. lactis and 























Fig. 3 Effect of aeration rate on end-products of glucose metabolism in the triple deletion mutant C. glutamicum ΔaceEΔpqoΔldhA(pEKEx2-
als,aldB,PtufbutA) (a) and the quadruple deletion mutant ΔaceEΔpqoΔldhAΔmdhA (pEKEx2-als,aldB,PtufbutA) (b). Fifty mL of cell suspension in 80-mL 
fermenter incubated with 2 % (wt/vol) glucose for 30 h at 30 °C. The air flow was 5, 10 or 20 mL/min. Red 2,3-BD; blue acetoin; magenta acetolactate; 
light green succinate; purple acetate; brown pyruvate; dark green α-ketoisovalerate; light grey α-ketoglutarate; black DHA; dark grey glycerol; pink 
ethanol; yellow l-alanine
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C. glutamicum is able to synthesize α-acetolactate from 
pyruvate via the action of the anabolic enzyme, AHAS; 
however, this enzyme is highly inhibited by the branched 
chain amino acids derived from α-acetolactate [39]. 
Therefore, our engineering strategy endowed the host 
strain with a heterologous ALS, i.e., the catabolic enzyme 
from L. lactis, which is not susceptible to amino acid 
inhibition [40]. The enhanced activity of ALS should also 
be beneficial for directing the flux towards 2,3-BD.
The second step in the biosynthetic pathway, decar-
boxylation of α-acetolactate into R-acetoin, is carried 
out by α-acetolactate decarboxylase. A homologue of 
this enzyme is not predicted in the genome of C. glu-
tamicum, and indeed the ALS/ALDC activity was low 
in cell extracts of all control strains (Table 2). The third 
step, reduction of acetoin, is performed by BDH, and a 
relatively high activity (0.2–0.3  U(mg protein)−1) was 
detected in the control strains (Table  2). Actually, this 
is not surprising given that C. glutamicum possesses 
(2S,3S)-BDH, which is claimed to be absolutely stere-
ospecific for S-acetoin [5]. Like all known ALDCs, the 
enzyme from L. lactis produces exclusively R-acetoin 
[41], thus a BDH with suitable stereospecific properties 
needed to be included.
1H-NMR can distinguish the optically active from the 
meso-form of 2,3-BD (Additional file 1: Fig. S3). Control 
strains produced only optically active 2,3-BD (Table  3), 
most likely derived from diacetyl formed via spontane-
ous decarboxylation of α-acetolactate in the presence 
of oxygen. Diacetyl is then converted to 2,3-(2S,3S)-BD 
in two reduction reactions catalyzed by the endogenous 
BDH (Fig.  1). In contrast to the control strains, meso-
2,3-BD was by far the main form synthesized by the 
producer strains, the optically active form (around 5  % 
of total 2,3-BD), being detected only in fermentations 
performed at the highest aeration rates, in agreement 
with the oxygen dependence of the spontaneous decar-
boxylation of α-acetolactate. Given that C. glutamicum 
lacks α-acetolactate decarboxylase, the presence of BDH 
in this bacterium is rather puzzling. Moreover, accord-
ing to a recent study, C. glutamicum BDH is a promis-
cuous enzyme that besides acetoin recognizes DHA as 
substrate, though with a low affinity (30  mM or higher 
DHA concentration needed for activity) [42]. Further 
work should be directed to clarify the physiological role 
of BDH in C. glutamicum.
The L. lactis genes (als, aldB, butA) were functionally 
expressed in the three host strains. The combined activity 
ALS/ALDC was in the range 0.4–1.4 U (mg of protein)−1 
for producer strains grown on acetate, corresponding to 
overexpression levels of 8–31-fold. Opportunely, the het-
erologous activities are comparable to those of glycolytic 
enzymes measured in crude extracts of C. glutamicum 
[43]. Overexpression of butA (encoding BDH activity) 
was similarly successful, yielding final BDH activity up to 
1.2 U (mg of protein)−1, which confirms the suitability of 
using the lactococcal genes for 2,3-BD production in C. 
glutamicum.
The introduction of the assembled pathway in C. glu-
tamicum ΔldhA enabled efficient redirection of the flux 
from pyruvate into 2,3-BD. However, the yield was rela-
tively low (0.3  mol per mol glucose) and the two major 
products were succinate and acetate. Hence, the next 
engineering step had the objective of suppressing acetate 
pathways; this proved to be crucial in the by-product 
elimination strategy, as the 2,3-BD yield doubled in the 
ΔaceEΔpqoΔldhA-derived producer strains (Table  3; 
Fig.  5). Additional inactivation of mdh did not improve 
the yield significantly, but there was a slight increase in 
productivity (Table 3).
Curiously, the strains derived from C. glutamicum 
ΔaceEΔpqoΔldhAΔmdh produced substantial amounts 
of succinate despite the intended suppression of suc-
cinate formation via the reductive branch of the TCA 
cycle [36]. The genome of C. glutamicum includes mdhB 
(cg0763), putatively assigned as malate/L-lactate dehy-
drogenase, hence this second activity may contribute to 
succinate formation. On the other hand, involvement of 
the glyoxylate shunt and/or the oxidative branch of the 
TCA cycle cannot be ruled out.
Glycerol was the second major side-product 
detected in C. glutamicum ΔaceEΔpqoΔldhA- and 
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Fig. 4 Fermentation profile of the best 2,3-BD producer strain C. 
glutamicum ΔaceEΔpqoΔldhAΔmdh(pEKEx2-als,aldB,PtufbutA) as a 
function of time. Fifty mL of cell suspension in 80-mL fermenter 
incubated with 2 % (wt/vol) glucose for 30 h at 30 °C. The air flow 
was 10 mL min−1. Error bars are shown as standard deviation of three 
independent replicates. Black coloured circle, biomass as OD600; white 
coloured circle pH value; red coloured triangle, 2,3-BD; blue coloured 
square, acetoin; brown coloured diamond glucose; green coloured circle 
α-ketoisovalerate; black coloured square DHA; grey coloured triangle 
glycerol; yellow coloured diamond l-alanine
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have been proposed for the synthesis of this polyol in 
C. glutamicum [42, 44]. Jojima and coworkers [42] pro-
posed that under oxygen-deprivation conditions glycerol 
is formed through reduction of DHA by the activity of 
endogenous BDH. On the other hand, DHA is a product of 
dihydroxyacetone-phosphate (DHAP) dephosphorylation 
via the respective phosphatase [45]. Therefore, endogenous 
BDH and DHAP phosphatase are obvious targets for inac-
tivation in further attempts to minimize side products. In 
this way, the electrons that are used for glycerol formation 
could be directed to acetoin reduction. The elimination of 
BDH would also be advantageous for the stereochemical 
purity of the desired end-product, since the small contami-
nation with the optically active form would vanish, though 
at the expense of some carbon loss in the form of diacetyl.
Under production conditions (oxygen limitation), it is 
anticipated that the BDH activity plays an important role 
in satisfying the redox balance via cofactor recycling. 
Further enhancement of BDH activity was attempted by 
including an additional promoter, but the BDH activity 
remained unchanged (Tables 2, 3). However, a high BDH 
activity would not fix the redox imbalance since the syn-
thesis of 2,3-BD results in net production of 1 mol NADH 
per mol of glucose consumed, and an additional sink for 
the reducing power becomes mandatory. Accordingly, 
providing controlled amounts of oxygen significantly 
improved GCR and 2,3-BD productivity.
Manipulation of oxygen availability had no clear 
impact on 2,3-BD yield, but was crucial to increase 
GCR, which reached maximal values of approx. 
21 nmol min−1 mg CDW−1, comparable to those of C. glu-
tamicum strains engineered for isobutanol production [20]. 
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Fig. 5 A summary of the stepwise systematic approach used to engineering C. glutamicum for the production of 2,3-BD. The values reflect the 
impact of the several steps on yield and productivity. Blue boxes refer to strain optimization steps, while the yellow box indicates the process optimi-
zation step. 2,3-BD 2,3-butanediol, Glc glucose
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than for ΔaceEΔpqoΔldhA(pEKEx2-als,aldB,PtufbutA) 
(Table  4). The reason could be related with the dif-
ferent BDH activity in these two strains (Table  2). 
The stronger activity in C. glutamicum ΔaceEΔpqo 
ΔldhAΔmdh(pEKEx2-als,aldB,PtufbutA) would pull the 
flux towards 2,3-BD more efficiently, with concomitant 
benefit on the rate of NAD+ regeneration, and hence 
on the GCR. Further increase in the air supply (from 10 
to 20  mL  min−1) had a negative impact on 2,3-BD yield, 
which is in conformity with the equivalent accumulation 
of acetoin. This shift in end-products towards compounds 
less reduced than 2,3-BD indicates that the competition of 
oxygen as an electron sink became excessive.
Thus far, Klebsiella spp., E. aerogenes and S. marcescens 
are the top producers of 2,3-BD (reviewed in [46]; see also 
Additional file 1: Table S5 and references therein, [47–49]), 
however, the pathogenicity of these strains is regarded as 
a disadvantage and hinders large-scale production. The 
best non-pathogenic producer is Paenibacillus polymyxa 
(72 g L−1 and about 2 g L−1 h−1), which grows in complex 
medium and has the drawback of producing exopolysac-
charides that increase the viscosity of the fermentation 
broth [13]. Engineered S. cerevisiae has a 0.29  g  L−1  h−1 
productivity and a yield of 0.70 mol 2,3-BD per mol glu-
cose, while engineered E. coli produces 1.19 g L−1 h−1 with 
a yield of 0.82 mol mol−1 [14, 15]. The theoretical maximal 
yield of 2,3-BD from glucose is 1 mol per mol (0.5 g per 
g), and it was almost reached with pathogenic (Klebsiella 
spp.), and non-pathogenic producers (Bacillus spp.) (Addi-
tional file  1: Table S5 and references therein). Compared 
with these non-native producers, the best C. glutami-
cum 2,3-BD producer, ΔaceEΔpqoΔldhAΔmdh(pEKEx2-
als,aldB,PtufbutA), has a productivity close to the lower 
limit (10.9  nmol  min−1  mg  CDW−1 corresponding to 
0.21 g L−1 h−1), and a good yield (0.66 mol 2,3-BD per mol 
glucose). Our work used cell suspensions at a relatively 
low OD600 (20–30, corresponding to about 5 g CDW L−1), 
but C. glutamicum can easily be grown to much higher 
cell density, allowing for higher 2,3-BD productivity dur-
ing the production phase. For example, the utilization 
of a high density bioreactor (50  g  CDW  L−1), as in [29], 
would lead to one order of magnitude greater productivity 
(around 2 g L−1 h−1), which compares well with that of the 
non-pathogenic natural producer [13]. Further increase in 
GCR of engineered C. glutamicum strains might be pos-
sible with a more fine manipulation of the oxygen supply 
conditions.
While this manuscript was in a late stage of prepara-
tion, a study was published by Yang et  al. [50] with the 
same purpose as ours, albeit using different engineering 
strategies, host strains and production process. The 2,3-
BD yield obtained was lower than that presented here 
(0.47 vs 0.66 mol per mol glucose), but a more extended 
comparison is hampered by the very different production 
processes used in the two studies.
Conclusions
By using a systematic approach C. glutamicum was success-
fully engineered for the production of 2,3-BD (Fig. 5). Organic 
acid production was strongly reduced or eliminated and 
adequate activities of the 2,3-BD biosynthetic pathway were 
achieved. By means of genetic engineering and manipulation 
of production conditions, productivity and yield were opti-
mized. Characterization of production provided insight into 
metabolic features of producer strains, and indicated direc-
tions for further rounds of strain improvement. Future work 
should aim at increasing 2,3-BD yield by eliminating the side-
products DHA and glycerol. By using the full potential of C. 
glutamicum, improvement of productivity and titer is also 
feasible. Additionally, we propose that the optimized con-
struct, under adequate aeration conditions, can be used as a 
GRAS-platform for production of acetoin, another valuable 
chemical widespread in the food industry as flavor enhancer. 
Alternatively, straightforward developments, e.g., omission of 
the butA gene in the artificial operon and disruption of endog-
enous BDH, are expected to yield efficient acetoin producers.
Methods
Bacterial strains and growth conditions
Strains and plasmids used in this work are shown in 
Table  1. Cells were grown aerobically in the 2× TY 
medium described by Sambrook and Green [51]. Medium 
was supplemented either with 0.5 % (wt/vol) glucose or 
with 1  % (wt/vol) potassium acetate. Plasmid-harbour-
ing strains were selected using kanamycin (25 μg mL−1). 
Gene expression was induced by using 0.5 mM isopropyl 
β-d-1-thiogalactopyranoside (IPTG). Cultivations were 
performed at 30  °C with constant agitation at 160  rpm 
and were initiated by addition of a pre-culture to an opti-
cal density at 600 nm (OD600) of about 0.3. Growth was 
monitored by measuring the OD600. Specific growth rates 
(μ) were calculated through linear regression of the plots 
of ln(OD600) versus time during the exponential growth 
phase. For growth characterization, samples (1 mL) were 
taken periodically and pH was measured.
For the molecular biology procedures, E. coli DH5α was 
grown in test tubes containing 5 mL of 2× TY medium at 
37 °C and 180 rpm. Plasmid selection was achieved using 
50 μg kanamycin per mL.
Construction of strains and plasmids
All primers used are listed in Additional file  1: Table 
S2. To construct control strain C. glutamicum ∆ldhA, 
deletion of ldhA (cg3219) gene was performed accord-
ing to [52], using the primer pairs described there. 
Deletion of the mdh (cg2613) gene in C. glutamicum 
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∆aceE∆pqo∆ldhA (aceE, cg2466; pqo, cg2891; [52]) was 
performed as described in [20]. Chromosomal DNA of 
L. lactis MG1363, isolated according to [53], was used as 
template in PCR amplifications. In the first cloning step, 
the α-acetolactate synthase gene (als) was amplified from 
L. lactis chromosome using primer pair als-FW and als-
RE and cloned into plasmid pEKEx2. In the second step, 
genes encoding the α-acetolactate decarboxylase (aldB) 
and 2,3-butanediol dehydrogenase (butA) of L. lactis 
were amplified using primers aldB-FW, aldB-RE, butA-
FW and butA-RE, ligated, and subsequently inserted 
into pEKEx2-als, giving pEKEx2-als,aldB,butA. Alter-
natively, gene butA fused with 185  bp region upstream 
of tuf gene (Ptuf) was synthesized by NZYTech (Lisbon, 
Portugal). Plasmid pUC57 containing Ptuf-butA fusion 
was amplified in E. coli DH5α and restricted using 
BamHI and KpnI. The Ptuf-butA fragment was purified 
from agarose gel and ligated to aldB, after which joint 
DNA fragment was inserted into pEKEx2-als, yielding 
pEKEx2-als,aldB,PtufbutA. Plasmids were obtained and 
maintained in E. coli DH5α. After verification of the cor-
rectness of the insert by sequencing (GATC, Konstanz, 
Germany), plasmids were isolated from E. coli and elec-
troporated into competent C. glutamicum cells using 
the procedure described in [54] and [55]. Then, plasmids 
were isolated from C. glutamicum in the following way: 
5  mL of overnight culture was centrifuged for 1  min at 
16,100×g and room temperature, to be re-suspended 
in 0.2  mL of solution A (50  mM glucose, 25  mM Tris–
HCl, 10  mM EDTA, pH 8.0, freshly prepared). One μL 
of RNAse A (10 mg mL−1), and 15 mg mL−1 (final con-
centration) lysozyme were added, and the lysis was 
performed for 1.5 h at 55  °C. After the initial lysis step, 
isolation was continued with comercially available kits 
according to supplier instructions (Qiagen MiniPrep or 
Illustra Plasmid Mini Preparation Kit, GE Healthcare). 
Isolated plasmids were used as templates for PCR ampli-
fication of the inserted genes. Amplified region sequence 
was confirmed to be correct by sequencing (GATC, Kon-
stanz, Germany).
Preparation of cell suspensions
Cells grown as described above were harvested 14 h after 
inoculation, centrifuged (3214×g, 10  min, 4  °C), and 
washed once with 0.9 % (wt/vol) NaCl. The resulting cell 
suspension was centrifuged (3214×g, 10  min, 4  °C) and 
the pellet was re-suspended in a minimal CGXII basal 
solution at pH 7.0, that contained per liter: 1 g KH2PO4, 
1  g K2HPO4, 21  g MOPS (3-[N-morpholino] propane-
sulfonic acid), 0.25 g MgSO4·7 H2O, 10 mg CaCl2·2 H2O 
[56]. Nitrogen sources (urea and (NH4)2SO4) were omit-
ted, in order to minimize the biosynthesis of amino acids 
during the production phase.
Two‑stage fermentations processes
C. glutamicum strains were grown and cell suspensions 
prepared as described above. For the second fermentation 
stage (production phase), 50 mL of cell suspension (OD600 
of 15–20) were placed in an 80-mL fermenter (mini-fer-
menter), kept at 30  °C with a water bath and mixed with 
a magnetic stirrer at 200 rpm. Aeration was performed by 
sparging sterile air at a rate of 5, 10 or 20 mL min−1. The 
oxygen electrode (InPro® 6100/320/T/N, Mettler Toledo), 
was used to attempt monitoring dissolved oxygen during 
the production stage. The electrode was calibrated to 0 and 
100 % after equilibration with pure argon and air, respec-
tively. Glucose was provided to a final concentration of 2 % 
(wt/vol) and samples were collected over a period of 30 h. 
For the first round evaluation of the performance of the 
several constructs, 25 mL of concentrated cell suspension 
(OD600 of between 20 and 30) were placed in 50 mL closed 
falcon tubes kept at 30  °C in a rotary shaker (180  rpm). 
Glucose was provided to a final concentration of 2 % (wt/
vol) and the fermentation was allowed to proceed for 48 h. 
Samples (1 mL) were centrifuged for 5 min at room tem-
perature and 16,100×g; supernatants were then separated 
and kept at −20 °C until further analysis. End-products of 
metabolism were quantified by using 1H-NMR.
Enzymatic activities
C. glutamicum strains were grown as described above 
and cell suspensions prepared in 50 mM PIPES at pH 7.0. 
Crude cell extracts were prepared by using glass beads 
(<106 μm) in a MiniBeadbeater-8 cell disrupter (Biospec 
Products) in 3 cycles of 1 min, with breaks of 3 min dur-
ing which the extracts were kept on ice. After disruption, 
extracts were centrifuged at 16,100×g for 20 min at 4 °C. 
All enzyme activities were assayed at 30 °C in a Beckman 
Coulter DU 800 spectrophotometer in 50 mM PIPES (pH 
7.0). One unit of enzyme activity corresponds to 1 μmol 
of substrate/product converted/formed per minute under 
the experimental conditions applied. The protein concen-
tration was determined using Pierce BCA Protein Assay 
Kit (Thermo Scientific). Specific activity was expressed 
as units (μmol min−1) per milligram of protein [U (mg of 
protein)−1]. α-Acetolactate synthase activity was deter-
mined as described by [57]. The reaction was stopped 
by the addition of 100 μL of 6 N H2SO4, and acetoin was 
quantified colorimetrically at 525  nm as described by 
Westerfeld [58]. Butanediol dehydrogenases were assayed 
as described by Stormer [59], in a modified reaction 
mixture containing 50  mM buffer, 0.2  mM NADH and 
2.5 mM racemic acetoin.
NMR spectroscopy
All 1H-NMR spectra were acquired on a Bruker AVANCE 
II + 400 MHz spectrometer (Bruker BioSpin GmbH) at 
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27  °C, using a BBO-F probe head. Pre-saturation of the 
residual water signal was applied. Acquisition parame-
ters: flip angle of 90°; 32 K acquisition data points; repeti-
tion delay of 31.5 s. Formate was used as a concentration 
standard. The high reproducibility of the NMR measure-
ments is illustrated in Additional file 1: Fig. S4 to justify 
the acquisition of a single spectrum for each biological 
replicate (Tables 3, 4).
Chemicals and reagents
For the molecular biology purposes, RNAse A and Pwo 
polymerase were purchased from Roche Life Science; 
lysozyme (Fluka) was purchased from Sigma-Aldrich, 
while all other enzymes were from New England Bio-
labs. Acetoin used in enzymatic assays was from 
Sigma-Aldrich. All other chemicals were commercially 
available reagent-grade (Sigma-Aldrich or Merck Sharp 
& Dohme).
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